Tripeptidyl peptidase 1

Intervention

1 paper3 findings

MeSH

  • 1 lab in 1 country
  • Funders: Batten Disease Support and Research Association and 5 more
  • Animals1

Outcomes

3

Neurological function

upin mice1

1 study
  1. Tripeptidyl peptidase 1 improves neurological function in mice.

    “Importantly, IV administration of TPP1 with the peptide significantly reduces brain lysosomal storage, increases lifespan and improves neurological function.”

    Animalsin LINCL micerecombinant TPP1 coadministered with a 36-residue Apolipoprotein E-derived peptide

    Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain

    Molecular therapy : the journal of the American Society of Gene Therapy26 Dec 2013

Lifespan

upin mice1

1 study
  1. Tripeptidyl peptidase 1 extends lifespan in mice.

    “Importantly, IV administration of TPP1 with the peptide significantly reduces brain lysosomal storage, increases lifespan and improves neurological function.”

    Animalsin LINCL micerecombinant TPP1 coadministered with a 36-residue Apolipoprotein E-derived peptide

    Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain

    Molecular therapy : the journal of the American Society of Gene Therapy26 Dec 2013

Lysosomal storage

downin mice1

1 study
  1. Tripeptidyl peptidase 1 decreases lysosomal storage in mice.

    “Importantly, IV administration of TPP1 with the peptide significantly reduces brain lysosomal storage, increases lifespan and improves neurological function.”

    Animalsin LINCL micerecombinant TPP1 coadministered with a 36-residue Apolipoprotein E-derived peptidebrain

    Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain

    Molecular therapy : the journal of the American Society of Gene Therapy26 Dec 2013

More on Lysosomal storage

Latest